Financial & SEC Reports
Here you will find a summary of Celldex Therapeutics, Inc.'s latest financial information.
Latest 10-Q
Latest Annual Report and 10-K
Latest Proxy Statement
Share Related Items
Market Capitalization (Mil) $ | 704.29 |
Shares Outstanding (Mil) | 39.57 |
Shares Outstanding, Average (FY) (Mil) | 14.51 |
Float (Mil) | 39.45 |
Data provided by Kaleidoscope.
FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.